Ghrelin O-acyltransferase (GOAT) enzyme is overexpressed in prostate cancer, and its levels are associated with patient's metabolic status: Potential value as a non-invasive biomarker.
Saved in:
| Title: | Ghrelin O-acyltransferase (GOAT) enzyme is overexpressed in prostate cancer, and its levels are associated with patient's metabolic status: Potential value as a non-invasive biomarker. |
|---|---|
| Authors: | Hormaechea-Agulla D; Maimonides Institute of Biomedical Research of Córdoba (IMIBIC), Córdoba, Spain; Department of Cell Biology, Physiology and Immunology, University of Córdoba, Córdoba, Spain; Hospital Universitario Reina Sofía (HURS), Córdoba, Spain; CIBERobn, Córdoba, Spain; ceiA3, Córdoba, Spain., Gómez-Gómez E; Maimonides Institute of Biomedical Research of Córdoba (IMIBIC), Córdoba, Spain; Hospital Universitario Reina Sofía (HURS), Córdoba, Spain; Urology Service, HURS, Córdoba, Spain., Ibáñez-Costa A; Maimonides Institute of Biomedical Research of Córdoba (IMIBIC), Córdoba, Spain; Department of Cell Biology, Physiology and Immunology, University of Córdoba, Córdoba, Spain; Hospital Universitario Reina Sofía (HURS), Córdoba, Spain; CIBERobn, Córdoba, Spain; ceiA3, Córdoba, Spain., Carrasco-Valiente J; Maimonides Institute of Biomedical Research of Córdoba (IMIBIC), Córdoba, Spain; Hospital Universitario Reina Sofía (HURS), Córdoba, Spain; Urology Service, HURS, Córdoba, Spain., Rivero-Cortés E; Maimonides Institute of Biomedical Research of Córdoba (IMIBIC), Córdoba, Spain; Department of Cell Biology, Physiology and Immunology, University of Córdoba, Córdoba, Spain; Hospital Universitario Reina Sofía (HURS), Córdoba, Spain; CIBERobn, Córdoba, Spain; ceiA3, Córdoba, Spain., L-López F; Maimonides Institute of Biomedical Research of Córdoba (IMIBIC), Córdoba, Spain; Department of Cell Biology, Physiology and Immunology, University of Córdoba, Córdoba, Spain; Hospital Universitario Reina Sofía (HURS), Córdoba, Spain; CIBERobn, Córdoba, Spain; ceiA3, Córdoba, Spain., Pedraza-Arevalo S; Maimonides Institute of Biomedical Research of Córdoba (IMIBIC), Córdoba, Spain; Department of Cell Biology, Physiology and Immunology, University of Córdoba, Córdoba, Spain; Hospital Universitario Reina Sofía (HURS), Córdoba, Spain; CIBERobn, Córdoba, Spain; ceiA3, Córdoba, Spain., Valero-Rosa J; Maimonides Institute of Biomedical Research of Córdoba (IMIBIC), Córdoba, Spain; Hospital Universitario Reina Sofía (HURS), Córdoba, Spain; Urology Service, HURS, Córdoba, Spain., Sánchez-Sánchez R; Maimonides Institute of Biomedical Research of Córdoba (IMIBIC), Córdoba, Spain; Hospital Universitario Reina Sofía (HURS), Córdoba, Spain; Anatomical Pathology Service, HURS, Córdoba, Spain., Ortega-Salas R; Maimonides Institute of Biomedical Research of Córdoba (IMIBIC), Córdoba, Spain; Hospital Universitario Reina Sofía (HURS), Córdoba, Spain; Anatomical Pathology Service, HURS, Córdoba, Spain., Moreno MM; Maimonides Institute of Biomedical Research of Córdoba (IMIBIC), Córdoba, Spain; Hospital Universitario Reina Sofía (HURS), Córdoba, Spain; Anatomical Pathology Service, HURS, Córdoba, Spain., Gahete MD; Maimonides Institute of Biomedical Research of Córdoba (IMIBIC), Córdoba, Spain; Department of Cell Biology, Physiology and Immunology, University of Córdoba, Córdoba, Spain; Hospital Universitario Reina Sofía (HURS), Córdoba, Spain; CIBERobn, Córdoba, Spain; ceiA3, Córdoba, Spain., López-Miranda J; Maimonides Institute of Biomedical Research of Córdoba (IMIBIC), Córdoba, Spain; Hospital Universitario Reina Sofía (HURS), Córdoba, Spain; CIBERobn, Córdoba, Spain; Lipids and Atherosclerosis Unit, HURS, Córdoba, Spain., Requena MJ; Maimonides Institute of Biomedical Research of Córdoba (IMIBIC), Córdoba, Spain; Hospital Universitario Reina Sofía (HURS), Córdoba, Spain; Urology Service, HURS, Córdoba, Spain., Castaño JP; Maimonides Institute of Biomedical Research of Córdoba (IMIBIC), Córdoba, Spain; Department of Cell Biology, Physiology and Immunology, University of Córdoba, Córdoba, Spain; Hospital Universitario Reina Sofía (HURS), Córdoba, Spain; CIBERobn, Córdoba, Spain; ceiA3, Córdoba, Spain. Electronic address: justo@uco.es., Luque RM; Maimonides Institute of Biomedical Research of Córdoba (IMIBIC), Córdoba, Spain; Department of Cell Biology, Physiology and Immunology, University of Córdoba, Córdoba, Spain; Hospital Universitario Reina Sofía (HURS), Córdoba, Spain; CIBERobn, Córdoba, Spain; ceiA3, Córdoba, Spain. Electronic address: raul.luque@uco.es. |
| Source: | Cancer letters [Cancer Lett] 2016 Dec 01; Vol. 383 (1), pp. 125-134. Date of Electronic Publication: 2016 Sep 28. |
| Publication Type: | Comparative Study; Journal Article |
| Journal Info: | Publisher: Elsevier Science Ireland Country of Publication: Ireland NLM ID: 7600053 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-7980 (Electronic) Linking ISSN: 03043835 NLM ISO Abbreviation: Cancer Lett Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
